Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03482219 · ClinicalTrials.gov registry record · NA
Rehabilitation for Arm Coordination and Hand Movement in Systemic Sclerosis
A NA study of Systemic Sclerosis and SSc, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT03482219 is a NA study of Systemic Sclerosis and SSc that has completed, run by University of Michigan. The registered enrollment target is 32 participants, below the 278-participant average among 26 other Systemic Sclerosis trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03482219, a NA study of Systemic Sclerosis and SSc, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test two rehabilitation programs to improve arm function for patients with scleroderma. This is a Phase 2 randomized controlled trial in which participants will be assessed at baseline, 8 weeks, and 18 weeks. Participants will be randomized into an intensive intervention (8 individual sessions of occupational therapy plus a home exercise app) versus a home app treatment alone. The results of this study will be used to design a large multi-site trial in which optimized rehabilitation strategies can be used to help patients improve their arm function.
Conditions Studied
Interventions
- OTHER Occupational therapy
- OTHER Home app intervention
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2018-04-16 |
| Est. Completion | 2020-09-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03482219
The ClinicalTrials.gov registry entry for NCT03482219 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 278-participant average among 26 other Systemic Sclerosis trials with a reported enrollment target (88% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Systemic Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Occupational therapy is the first listed.
NCT03482219 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03482219 about?
NCT03482219 is a clinical study titled "Rehabilitation for Arm Coordination and Hand Movement in Systemic Sclerosis". The purpose of this study is to test two rehabilitation programs to improve arm function for patients with scleroderma. This is a Phase 2 randomized controlled trial in which participants will be assessed at baseline, 8 weeks, and 18 weeks. Participants will be randomized into an intensive intervent...
What is the current status of trial NCT03482219?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2018-04-16. Estimated completion is 2020-09-26.
What conditions does trial NCT03482219 study?
This clinical trial studies the following conditions: Systemic Sclerosis, SSc.
What interventions are being tested in trial NCT03482219?
The interventions under investigation include: Occupational therapy (OTHER), Home app intervention (OTHER).
Who is sponsoring clinical trial NCT03482219?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03482219 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Systemic Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
RECRUITING · NA
-
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
ACTIVE NOT RECRUITING · NA
-
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
RECRUITING · Phase 2
-
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RECRUITING · Phase 1
-
A Study of AZD0120 in Autoimmune Diseases
RECRUITING · Phase 1
-
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.